SHUKRA PHARMACEUTICALS
|
SHUKRA PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹59 Cr | ₹20 Cr | ₹11 Cr | ₹1,373,433 Cr | ₹6.61 Cr |
Sales | ₹47 Cr | ₹10 Cr | ₹4.70 Cr | ₹633,646 Cr | ₹2.30 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹2.18 Cr | ₹2.57 Cr | ₹0.28 Cr | - | ₹0.02 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹10 Cr | ₹7.59 Cr | ₹6.22 Cr | ₹739,787 Cr | ₹4.29 Cr |
Less: Excise Duty | - | - | - | ₹188,831 Cr | ₹0.95 Cr |
Net Sales | ₹59 Cr | ₹20 Cr | ₹11 Cr | ₹1,184,602 Cr | ₹5.66 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-0.33 Cr | ₹-0.73 Cr | ₹-0.19 Cr | ₹-32,687 Cr | ₹-0.17 Cr |
Raw Material Consumed | ₹46 Cr | ₹11 Cr | ₹2.96 Cr | ₹332,817 Cr | ₹1.16 Cr |
Opening Raw Materials | ₹2.50 Cr | ₹0.96 Cr | ₹0.86 Cr | ₹7,190 Cr | ₹0.11 Cr |
Purchases Raw Materials | ₹7.17 Cr | ₹9.40 Cr | ₹2.95 Cr | ₹399,243 Cr | ₹1.04 Cr |
Closing Raw Materials | ₹1.37 Cr | ₹2.50 Cr | ₹0.96 Cr | ₹86,096 Cr | ₹0.07 Cr |
Other Direct Purchases / Brought in cost | ₹37 Cr | ₹3.22 Cr | ₹0.12 Cr | ₹12,481 Cr | ₹0.07 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | - | - | ₹1.78 Cr | ₹163,585 Cr | ₹0.34 Cr |
Electricity & Power | - | - | ₹1.78 Cr | ₹163,585 Cr | ₹0.34 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹4.41 Cr | ₹4.57 Cr | ₹3.75 Cr | ₹433,800 Cr | ₹1.91 Cr |
Salaries, Wages & Bonus | ₹4.39 Cr | ₹4.56 Cr | ₹3.69 Cr | ₹417,553 Cr | ₹1.86 Cr |
Contributions to EPF & Pension Funds | ₹0.01 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹14,554 Cr | ₹0.02 Cr |
Workmen and Staff Welfare Expenses | ₹0.01 Cr | ₹0.00 Cr | ₹0.02 Cr | ₹1,693 Cr | ₹0.03 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹0.12 Cr | ₹0.09 Cr | ₹0.05 Cr | ₹2,834 Cr | ₹0.02 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | - | - | - | ₹2,398 Cr | ₹0.01 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹0.12 Cr | ₹0.09 Cr | ₹0.05 Cr | ₹436 Cr | ₹0.02 Cr |
General and Administration Expenses | ₹3.36 Cr | ₹2.50 Cr | ₹1.35 Cr | ₹129,339 Cr | ₹0.73 Cr |
Rent , Rates & Taxes | ₹0.55 Cr | ₹0.71 Cr | ₹0.55 Cr | ₹58,991 Cr | ₹0.33 Cr |
Insurance | ₹0.05 Cr | ₹0.07 Cr | ₹0.02 Cr | ₹3,298 Cr | ₹0.03 Cr |
Printing and stationery | ₹0.05 Cr | ₹0.06 Cr | ₹0.01 Cr | ₹1,949 Cr | ₹0.02 Cr |
Professional and legal fees | ₹0.36 Cr | ₹0.30 Cr | ₹0.22 Cr | ₹15,530 Cr | ₹0.09 Cr |
Traveling and conveyance | ₹0.24 Cr | ₹0.04 Cr | ₹0.03 Cr | ₹12,206 Cr | ₹0.00 Cr |
Other Administration | ₹2.10 Cr | ₹1.32 Cr | ₹0.51 Cr | ₹37,365 Cr | ₹0.27 Cr |
Selling and Distribution Expenses | ₹0.01 Cr | ₹0.01 Cr | ₹0.04 Cr | ₹236 Cr | ₹0.02 Cr |
Advertisement & Sales Promotion | ₹0.01 Cr | ₹0.01 Cr | ₹0.04 Cr | ₹183 Cr | ₹0.02 Cr |
Sales Commissions & Incentives | - | - | - | ₹53 Cr | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | ₹0.01 Cr | - | - | - |
Miscellaneous Expenses | ₹0.26 Cr | ₹0.07 Cr | ₹0.01 Cr | ₹642 Cr | - |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.26 Cr | ₹0.07 Cr | ₹0.01 Cr | ₹642 Cr | - |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹53 Cr | ₹18 Cr | ₹9.75 Cr | ₹1,030,567 Cr | ₹4.01 Cr |
Operating Profit (Excl OI) | ₹5.36 Cr | ₹2.89 Cr | ₹1.44 Cr | ₹154,035 Cr | ₹1.65 Cr |
Other Income | ₹1.20 Cr | ₹0.08 Cr | ₹0.36 Cr | ₹970 Cr | ₹0.04 Cr |
Interest Received | ₹0.06 Cr | ₹0.03 Cr | ₹0.05 Cr | ₹847 Cr | ₹0.01 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹0.44 Cr | ₹0.03 Cr | - | - | - |
Foreign Exchange Gains | - | - | - | ₹111 Cr | - |
Others | ₹0.70 Cr | ₹0.02 Cr | ₹0.31 Cr | ₹13 Cr | ₹0.03 Cr |
Operating Profit | ₹6.56 Cr | ₹2.97 Cr | ₹1.80 Cr | ₹155,006 Cr | ₹1.69 Cr |
Interest | ₹0.28 Cr | ₹0.29 Cr | ₹0.03 Cr | ₹206 Cr | ₹0.00 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.03 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹206 Cr | ₹0.00 Cr |
Other Interest | ₹0.26 Cr | ₹0.28 Cr | ₹0.01 Cr | - | - |
PBDT | ₹6.28 Cr | ₹2.68 Cr | ₹1.77 Cr | ₹154,800 Cr | ₹1.69 Cr |
Depreciation | ₹1.84 Cr | ₹1.66 Cr | ₹1.47 Cr | ₹147,819 Cr | ₹0.96 Cr |
Profit Before Taxation & Exceptional Items | ₹4.44 Cr | ₹1.02 Cr | ₹0.29 Cr | ₹6,981 Cr | ₹0.72 Cr |
Exceptional Income / Expenses | - | - | ₹-0.20 Cr | ₹10,103 Cr | - |
Profit Before Tax | ₹4.44 Cr | ₹1.02 Cr | ₹0.10 Cr | ₹17,084 Cr | ₹0.72 Cr |
Provision for Tax | ₹0.04 Cr | ₹0.27 Cr | ₹-0.09 Cr | ₹13,524 Cr | ₹0.26 Cr |
Current Income Tax | - | ₹0.18 Cr | ₹0.02 Cr | - | ₹0.15 Cr |
Deferred Tax | ₹0.03 Cr | ₹0.06 Cr | ₹0.11 Cr | ₹13,524 Cr | ₹0.12 Cr |
Other taxes | ₹0.01 Cr | ₹0.04 Cr | ₹-0.21 Cr | - | - |
Profit After Tax | ₹4.41 Cr | ₹0.75 Cr | ₹0.19 Cr | ₹3,560 Cr | ₹0.46 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹965,031 Cr | ₹9.19 Cr |
Appropriations | ₹19 Cr | ₹15 Cr | ₹14 Cr | ₹968,592 Cr | ₹9.65 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹0.08 Cr | - | - | - | - |
Equity Dividend % | ₹5.00 | ₹5.00 | - | - | ₹5.00 |
Earnings Per Share | ₹11.26 | ₹4.79 | ₹1.20 | ₹0.23 | ₹2.95 |
Adjusted EPS | ₹2.81 | ₹0.25 | ₹0.06 | ₹0.01 | ₹0.15 |
Compare Income Statement of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹491.4 Cr | 21.5% | 86% | 227.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,103.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,540.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹119,196.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,752.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,041.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | 21.5% |
86% |
227.7% |
SENSEX | -2.7% |
-0.8% |
9.9% |
You may also like the below Video Courses